MFDS
- Marketing authorisation holder: SPRINGWORKS
- Status: likely_approved
🇰🇷 Ogsiveo in South Korea
Ogsiveo (NIROGACESTAT) regulatory status in South Korea.
Marketing authorisation
Ogsiveo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Ogsiveo approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Ogsiveo in South Korea?
SPRINGWORKS holds the South Korean marketing authorisation.